Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. II. The effect of hydroxy bis-[2-(-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in hypercholesterolimic rats.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D002791:Cholesterol, Dietary; D002994:Clofibrate / Q000627:therapeutic use*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D006937:Hypercholesterolemia / Q000188:drug therapy*; D007668:Kidney / Q000378:metabolism; D050356:Lipid Metabolism; D008077:Lipoproteins, LDL / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009929:Organ Size; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D013737:Testis / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D005230:Fatty Acids, Nonesterified; D008077:Lipoproteins, LDL; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate